Fabp7tm2(cre/PGR*)Ksak
Targeted Allele Detail
|
Symbol: |
Fabp7tm2(cre/PGR*)Ksak |
Name: |
fatty acid binding protein 7, brain; targeted mutation 2, Kenji Sakimura |
MGI ID: |
MGI:4360725 |
Synonyms: |
BFABP-CrePR, Fabp7tm1(crePR)Ksak, Fabp7tm2(cre/PGR)Ksak |
Gene: |
Fabp7 Location: Chr10:57661019-57664546 bp, + strand Genetic Position: Chr10, 29.25 cM
|
Alliance: |
Fabp7tm2(cre/PGR*)Ksak page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:104881
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Targeted (Inducible, Recombinase) |
Inducer: |
|
mifepristone |
Mutation: |
|
Insertion
|
|
|
Fabp7tm2(cre/PGR*)Ksak expression driven by
1 gene
Knock-in expression driven by:
Organism |
Driver Gene |
Note |
mouse |
Fabp7 (MGI:101916) |
|
|
|
|
Mutation details: The endogenous gene's promoter drives expression of a DNA sequence encoding a fusion protein in which Cre recombinase is joined to the ligand binding domain (LBD) of the human progesterone receptor lacking the carboxyl terminal 42 amino acids. The chimeric recombinase protein is not constitutively active; its activity is inducible by binding of the synthetic progesterone analog RU486 to the truncated progesterone LBD.
(J:104881, J:122587)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Fabp7
(mouse)
|
|
|
|
|
Original: |
J:104881 The RIKEN BioResource Center, Information obtained from The RIKEN BioResource Center. Unpublished. 2006-2013; |
All: |
2 reference(s) |
|